Excess cancer incidence and mortality among patients with systemic lupus erythematosus: a population-based study in New Zealand
New Zealand Medical Journal · 2025
DOI: 10.26635/6965.7179 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Zealand Medical Journal, 2025. Verfasst von Chunhuan Lao und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Equity and Innovation, the University of Waikato, Hamilton, New Zealand. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Neoplasms. Gefördert von: Arthritis New Zealand financial support (Lupus/SLE Postdoctoral Fellowship for Dr Chunhuan Lao).
Abstract (Originalsprache)
aim: This study aims to investigate the cancer incidence and mortality among patients with systemic lupus erythematosus (SLE) in New Zealand. methods: SLE patients were linked to the New Zealand Cancer Registry to identify cancer cases. The cancer incidence rate and cancer mortality rate among SLE patients in 2010–2021 were age-standardised to the general population. The estimations were stratified by cancer site, sex, ethnicity and age group. results: Among 2,656 SLE patients, 240 new cancer cases were identified, including 187 women and 53 men. Haematologic cancers accounted for 20% of cancer cases identified. The relative risk of cancer incidence for SLE patients compared to the general population was 1.48 (95% confidence interval [CI] 1.28–1.71) for women and 2.08 (95% CI 1.59–2.73) for men. The relative risk of cancer death for SLE patients compared to the general population was 1.75 (95% CI 1.40–2.19) for women and 2.27 (95% CI 1.49–3.44) for men. Younger patients had greater relative risks of cancer incidence and cancer mortality than older patients. conclusions: Patients with SLE in New Zealand experience a higher cancer burden compared to the general population, with greater disparity among younger patients and male patients. Haematologic cancers were especially prevalent among SLE patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Health Equity and Innovation, the University of Waikato, Hamilton, New Zealand.
- Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
- School of Medicine, the University of Waikato, Hamilton, New Zealand.
- Rheumatology Department, Waikato Hospital, Hamilton, New Zealand; Waikato Clinical School, The University of Auckland, Auckland, New Zealand.
Förderung
- Arthritis New Zealand financial support (Lupus/SLE Postdoctoral Fellowship for Dr Chunhuan Lao)
Zitieren
APA
Lao, C., Tugnet, N., Lawrenson, R., & White, D. (2025). Excess cancer incidence and mortality among patients with systemic lupus erythematosus: a population-based study in New Zealand. New Zealand Medical Journal. https://doi.org/10.26635/6965.7179
Vancouver
Lao C, Tugnet N, Lawrenson R, White D. Excess cancer incidence and mortality among patients with systemic lupus erythematosus: a population-based study in New Zealand. New Zealand Medical Journal. 2025. doi:10.26635/6965.7179
BibTeX
@article{Lao2025,
author = {Lao, Chunhuan and Tugnet, Nicola and Lawrenson, Ross and White, Douglas},
title = {Excess cancer incidence and mortality among patients with systemic lupus erythematosus: a population-based study in New Zealand},
journal = {New Zealand Medical Journal},
year = {2025},
doi = {10.26635/6965.7179}
}
EUVIMED